SCHEMBL22388787

SCHEMBL22388787

CC(C)(C)c1cnn(-c2ccc(N3CCOCC3)cn2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.48
ALDH1A1 P00352 6/20 0.48
LMNA P02545 3/20 0.48
HSD17B10 Q99714 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 2/20 0.48
HTT P42858 2/20 0.48
HPGD P15428 2/20 0.48
GAA P10253 1/20 0.48
RECQL P46063 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
POLB P06746 1/20 0.42
BRD4 O60885 1/20 0.39
PRKDC P78527 1/20 0.38
USP2 O75604 1/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22388784 0.86 MAPT (0.46) MAPTALDH1A1LMNAHSD17B10MEN1
SCHEMBL22388786 0.86 MELK (0.43) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL22388788 0.85 CHRNB2 (0.47) OPRM1OPRL1
SCHEMBL20847627 0.83 MAPT (0.55) MAPTALDH1A1LMNAHSD17B10MEN1
SCHEMBL25999238 0.78 MAPT (0.46) MAPTALDH1A1LMNAHSD17B10MEN1
SCHEMBL22388842 0.77 CYP2D6 (0.43) ALDH1A1
SCHEMBL22388782 0.77 GPR119 (0.48) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL14008911 0.73 POLB (0.55) MAPTALDH1A1LMNAHSD17B10MEN1
SCHEMBL16543461 0.73 GCG (0.38) MAPTALDH1A1SMN1; SMN2KDM4ETP53
SCHEMBL2616405 0.73 ALDH1A1 (0.55) MAPTALDH1A1LMNAHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200277268-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF DALRIADA THERAPEUTICS INC. (CA) 2020-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200277268-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF MKI67, PKD1, ETV6 MAPT 4206/4885ALDH1A1 848/4885LMNA 2423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.